| NCT06944717 | A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old | ACTIVE_NOT_RECRUITING | PHASE1 | 2025-03-03 | 2026-05-01 | 2026-05-01 |
| NCT06672055 | A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection | RECRUITING | PHASE2 | 2024-10-08 | 2026-11 | 2026-11 |
| NCT05626803 | A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers | COMPLETED | PHASE2 | 2023-01-26 | 2023-10-16 | 2023-10-16 |
| NCT05213728 | A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers | COMPLETED | PHASE1 | 2022-01-24 | 2022-02-24 | 2022-02-01 |
| NCT05212168 | Norovirus Challenge Study | COMPLETED | PHASE1, PHASE2 | 2021-12-27 | 2023-10-27 | 2023-04-13 |
| NCT05067933 | A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine | TERMINATED | PHASE2 | 2021-10-22 | 2023-05-09 | 2022-06-10 |
| NCT04875676 | Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines | COMPLETED | PHASE1, PHASE2 | 2021-04-30 | 2022-02-16 | 2021-10-30 |
| NCT04854746 | Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine | COMPLETED | PHASE1 | 2021-04-26 | 2022-01-04 | 2022-01-04 |
| NCT04563702 | Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects | COMPLETED | PHASE1 | 2020-09-21 | 2021-10-10 | 2021-10-10 |
| NCT03897309 | Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines | COMPLETED | PHASE1 | 2019-03-20 | 2021-04-01 | 2021-01-15 |
| NCT03125473 | Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers | COMPLETED | PHASE1 | 2017-04-07 | 2018-05-06 | 2017-07-01 |
| NCT03121339 | Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2017-03-31 | 2018-04-03 | 2017-05-05 |
| NCT02918006 | A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine | COMPLETED | PHASE2 | 2016-08-31 | 2018-01-19 | 2017-08-08 |
| NCT02868073 | Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine | COMPLETED | PHASE1 | 2016-07-29 | 2017-10-01 | 2016-10-05 |
| NCT02830932 | Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f) | COMPLETED | PHASE1 | 2016-06-22 | 2017-09-20 | 2016-09-16 |
| NCT02877264 | A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers | COMPLETED | PHASE1 | 2016-06 | | 2016-08 |
| NCT02718937 | Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study | COMPLETED | PHASE2 | 2016-03 | 2016-12 | 2016-12 |
| NCT02724254 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | COMPLETED | PHASE2 | 2016-01 | 2018-07 | 2018-05 |
| NCT02668367 | Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers | COMPLETED | PHASE1 | 2015-11 | 2016-02 | 2016-02 |
| NCT02547792 | Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults | COMPLETED | PHASE1 | 2015-10-20 | 2016-11-21 | 2016-11-21 |
| NCT02558413 | Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers | COMPLETED | PHASE1 | 2015-08 | 2015-12 | 2015-12 |
| NCT02367313 | A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection | COMPLETED | PHASE2 | 2015-02 | 2016-12 | 2016-12 |
| NCT02204501 | A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers | COMPLETED | PHASE1 | 2014-05 | 2014-06 | 2014-06 |
| NCT02101866 | A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers | COMPLETED | PHASE1 | 2014-03 | 2014-06 | 2014-05 |
| NCT02014649 | Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza | TERMINATED | PHASE1, PHASE2 | 2013-11 | 2014-05 | 2014-04 |
| NCT02022761 | Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma | COMPLETED | PHASE1 | 2013-10 | 2014-02 | 2013-10 |
| NCT01793883 | Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza | COMPLETED | PHASE2 | 2013-05 | 2014-05 | 2014-05 |
| NCT01761123 | Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum | COMPLETED | PHASE1 | 2013-01 | 2014-10 | 2014-10 |
| NCT01688297 | Safety Study of an Oral Vaccine to Prevent Seasonal Influenza | COMPLETED | PHASE1 | 2012-09 | 2015-04 | 2014-05 |
| NCT01698060 | Immunogenicity of ND1.1 by Delivery Directly to the Ileum | COMPLETED | PHASE1 | 2012-09 | 2013-11 | 2013-11 |
| NCT01532102 | Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts | COMPLETED | PHASE1, PHASE2 | 2012-02-28 | 2013-05-06 | 2013-05-06 |
| NCT01335347 | Safety Study of an Oral Vaccine to Prevent Avian Influenza | COMPLETED | PHASE1 | 2011-04 | 2012-09 | 2012-08 |
| NCT01175226 | A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection | COMPLETED | PHASE2 | 2010-08 | 2012-03 | 2012-03 |
| NCT00995826 | Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958 | COMPLETED | PHASE1 | 2009-04 | 2009-11 | 2009-09 |
| NCT00657111 | CS-8958 Single Inhaled Dose in Elderly | COMPLETED | PHASE1 | 2008-04 | 2009-10 | 2009-10 |
| NCT00504907 | Safety Study of Oral BTA9881 to Treat RSV Infection | COMPLETED | PHASE1 | 2007-07 | 2008-12 | 2008-12 |
| NCT00311714 | Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 | COMPLETED | PHASE1 | 2007-04 | 2007-12 | |
| NCT03024177 | A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection | WITHDRAWN | PHASE2 | | | 2017-04 |